相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells
S. M. Cheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Huaier Extract Induces Autophagic Cell Death by Inhibiting the mTOR/S6K Pathway in Breast Cancer Cells
Xiaolong Wang et al.
PLOS ONE (2015)
Arginine deprivation and autophagic cell death in cancer
Peter Wojciech Szlosarek
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Treat cancers by targeting survivin: Just a dream or future reality?
Mohane Selvaraj Coumar et al.
CANCER TREATMENT REVIEWS (2013)
Inactivation of HDAC3 and STAT3 is Critically Involved in 1-Stearoyl-sn-Glycero-3-Phosphocholine-Induced Apoptosis in Chronic Myelogenous Leukemia K562 Cells
Ji Hoon Jung et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling
Xing Huang et al.
EMBO JOURNAL (2013)
Autophagy Controls p38 Activation to Promote Cell Survival under Genotoxic Stress
Lei Qiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
Jesse E. Hanson et al.
PLOS ONE (2013)
Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells
Young Ju Lee et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)
Histone Deacetylase 6 (HDAC6) Deacetylates Survivin for Its Nuclear Export in Breast Cancer
Matthew T. Riolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells
Qinwen Wang et al.
CANCER LETTERS (2011)
XIAP is not required for human tumor cell survival in the absence of an exogenous death signal
John Sensintaffar et al.
BMC CANCER (2010)
MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity
Euphemia Leung et al.
CANCER BIOLOGY & THERAPY (2010)
A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy
Chun Hei Antonio Cheung et al.
CANCER CELL INTERNATIONAL (2010)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
Yi-kang Shi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity
Haijuan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
F. Condorelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Nuclear survivin has reduced stability and is not cytoprotective
Claire M. Connell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Autophagy is activated for cell survival after endoplasmic reticulum stress
Maiko Ogata et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Autophagy: Dual roles in life and death?
EH Baehrecke
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells
MS Roh et al.
APOPTOSIS (2004)
Regulation of survivin function by Hsp90
P Fortugno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Survivin, versatile modulation of cell division and apoptosis in cancer
DC Altieri
ONCOGENE (2003)
Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis
PR Potts et al.
JOURNAL OF CELL BIOLOGY (2003)
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
A Mirza et al.
ONCOGENE (2002)
The lysosomotropic agent monodansylcadaverine also acts as a solvent polarity probe
A Niemann et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
分享论文
